1044 related articles for article (PubMed ID: 10433620)
1. Cancer risks in BRCA2 mutation carriers.
Breast Cancer Linkage Consortium
J Natl Cancer Inst; 1999 Aug; 91(15):1310-6. PubMed ID: 10433620
[TBL] [Abstract][Full Text] [Related]
2. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
van Asperen CJ; Brohet RM; Meijers-Heijboer EJ; Hoogerbrugge N; Verhoef S; Vasen HF; Ausems MG; Menko FH; Gomez Garcia EB; Klijn JG; Hogervorst FB; van Houwelingen JC; van't Veer LJ; Rookus MA; van Leeuwen FE;
J Med Genet; 2005 Sep; 42(9):711-9. PubMed ID: 16141007
[TBL] [Abstract][Full Text] [Related]
4. The effect of a single BRCA2 mutation on cancer in Iceland.
Tulinius H; Olafsdottir GH; Sigvaldason H; Arason A; Barkardottir RB; Egilsson V; Ogmundsdottir HM; Tryggvadottir L; Gudlaugsdottir S; Eyfjord JE
J Med Genet; 2002 Jul; 39(7):457-62. PubMed ID: 12114473
[TBL] [Abstract][Full Text] [Related]
5. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
[TBL] [Abstract][Full Text] [Related]
6. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Ford D; Easton DF; Bishop DT; Narod SA; Goldgar DE
Lancet; 1994 Mar; 343(8899):692-5. PubMed ID: 7907678
[TBL] [Abstract][Full Text] [Related]
7. Cancer Risks Associated With
Li S; Silvestri V; Leslie G; Rebbeck TR; Neuhausen SL; Hopper JL; Nielsen HR; Lee A; Yang X; McGuffog L; Parsons MT; Andrulis IL; Arnold N; Belotti M; Borg Å; Buecher B; Buys SS; Caputo SM; Chung WK; Colas C; Colonna SV; Cook J; Daly MB; de la Hoya M; de Pauw A; Delhomelle H; Eason J; Engel C; Evans DG; Faust U; Fehm TN; Fostira F; Fountzilas G; Frone M; Garcia-Barberan V; Garre P; Gauthier-Villars M; Gehrig A; Glendon G; Goldgar DE; Golmard L; Greene MH; Hahnen E; Hamann U; Hanson H; Hassan T; Hentschel J; Horvath J; Izatt L; Janavicius R; Jiao Y; John EM; Karlan BY; Kim SW; Konstantopoulou I; Kwong A; Laugé A; Lee JW; Lesueur F; Mebirouk N; Meindl A; Mouret-Fourme E; Musgrave H; Ngeow Yuen Yie J; Niederacher D; Park SK; Pedersen IS; Ramser J; Ramus SJ; Rantala J; Rashid MU; Reichl F; Ritter J; Rump A; Santamariña M; Saule C; Schmidt G; Schmutzler RK; Senter L; Shariff S; Singer CF; Southey MC; Stoppa-Lyonnet D; Sutter C; Tan Y; Teo SH; Terry MB; Thomassen M; Tischkowitz M; Toland AE; Torres D; Vega A; Wagner SA; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Spurdle AB; Easton DF; Chenevix-Trench G; Ottini L; Antoniou AC
J Clin Oncol; 2022 May; 40(14):1529-1541. PubMed ID: 35077220
[TBL] [Abstract][Full Text] [Related]
8. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
[TBL] [Abstract][Full Text] [Related]
9. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
Moran A; O'Hara C; Khan S; Shack L; Woodward E; Maher ER; Lalloo F; Evans DG
Fam Cancer; 2012 Jun; 11(2):235-42. PubMed ID: 22187320
[TBL] [Abstract][Full Text] [Related]
10. Cancer Incidence in BRCA1 mutation carriers.
Thompson D; Easton DF;
J Natl Cancer Inst; 2002 Sep; 94(18):1358-65. PubMed ID: 12237281
[TBL] [Abstract][Full Text] [Related]
11. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
[TBL] [Abstract][Full Text] [Related]
12. Cancer variation associated with the position of the mutation in the BRCA2 gene.
Lubinski J; Phelan CM; Ghadirian P; Lynch HT; Garber J; Weber B; Tung N; Horsman D; Isaacs C; Monteiro AN; Sun P; Narod SA
Fam Cancer; 2004; 3(1):1-10. PubMed ID: 15131399
[TBL] [Abstract][Full Text] [Related]
13. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.
Thompson D; Easton D;
Am J Hum Genet; 2001 Feb; 68(2):410-9. PubMed ID: 11170890
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
15. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
16. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
Mai PL; Chatterjee N; Hartge P; Tucker M; Brody L; Struewing JP; Wacholder S
PLoS One; 2009; 4(3):e4812. PubMed ID: 19277124
[TBL] [Abstract][Full Text] [Related]
17. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
18. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
[TBL] [Abstract][Full Text] [Related]
19. Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
Streff H; Profato J; Ye Y; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
Oncologist; 2016 Jul; 21(7):869-74. PubMed ID: 27306910
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]